TTS Ltd and AusBiotech are pleased to announce that TTS Australia, the premier global meeting of technology transfer, is back for 2018. The two-day conference will take place on April 17 and 18 at the University of Queensland's Customs House in Brisbane.
TTS Australia will seek to deliver direct interaction with innovators representing international leading universities, research institutions and science parks, as well as biotech CEOs and local biotech sector leaders and is an excellent opportunity for accessing world-class science.
Delegates have the opportunity to take part in open discussions and debates on best practices, lessons learned and key issues such as negotiations, strategic industry research collaborations, IP and commercial negotiation. There is the opportunity to connect with industry representatives seeking to fill pipelines and access an ideal source of deal-flow from leading universities and research institutes across Australia.
Key topics to be covered at the two-day event include:
- Translational research as a key driver for innovation in Biotech and Healthcare;
- Engaging with the NIH;
- What makes a successful tech transfer professional;
- Successful product development for medical devices;
- Update on the Biomedical translation fund;
- Alternative sources of funding and investment; and
- Big Pharma.
TTS Global Initiative
TTS Australia is one chapter of a global initiative; with other summits in Europe and North America. The global initiative has been a leading international meeting for the biotech sector – including academia, licensing, partnering & technology transfer professionals. Designed to help build expertise and relationships that enable successful tech transfer officers sign deals and licensing agreements, the summits are pillars of this key international initiative and unite the community of the leading technology transfer professionals, licensing, IP and early-stage biotech innovation and venture professionals worldwide.
Why attend TTS Australia?
- For technology transfer professionals, the summit is where innovators will come to meet and build relationships. The two-day program will facilitate open discussions and debates on best practices, lessons learned and key issues such as negotiations, strategic industry-research collaborations, IP and commercial negotiation;
- Universities, research institutes and science parks will have the opportunity to meet with senior international industry licensing and business development executives, investors, biotech sector leaders, IP experts and entrepreneurs; and
- For industry licensing executives, external R&D directors, business development managers and biotech CEOs seeking to fill pipelines, the summit will be an ideal source of deal-flow from leading universities and research institutes across Australia.
Register now to build the knowledge and relationships that are essential to progressing your commercialisation of life science activities.